Cellular senescence is considered a key biological program that can exert both protective and potentially pathogenic effects in tissues across the lifespan. If senescent cells persist, they are associated with chronic inflammation, disturbed tissue homeostasis and diverse disease phenotypes. In recent years, a clinically highly relevant field of research has emerged from this: Senotherapies – in particular senolytics (selective elimination of senescent cells) and senomorphics (modulation of senescence-associated signaling and secretion patterns) – are widely studied in preclinical models, while human evidence to date comes mainly from early, small studies or from indirect clinical data sets.
You May Also Like
- Psychedelic-assisted therapy
Current status of PAT
- Osgood-Schlatter Disease
Clinical Presentation, Diagnosis, and Treatment
- Cardiovascular Risk in Rheumatoid Arthritis
What is the most dangerous thing for RA?
- Antisense oligonucleotide for severe hypertriglyceridemia
Reduced Incidence of Acute Pancreatitis
- Hereditary Transthyretin Amyloidosis with Polyneuropathy
New Treatment Options for ATTRv-PN
- Type 1 Diabetes: A New Disease-Modifying Treatment Approach
Slowing the loss of β-cell function and delaying the progression of the disease
- Liver Cancer
Artificial Intelligence in Precision Oncology—Opportunities and Challenges
- Acute nonspecific back pain